| Literature DB >> 32140442 |
Martha Ervina1,2, Hadi Poerwono3, Retno Widyowati4, Katsuyoshi Matsunami5.
Abstract
Melia azedarach L. is used widely in traditional medicine for local or systemic ailments. Although studies exist on phytochemicals and potencies of Chinese and Indian cultivars of Melia, the present study investigated in vitro antioxidant properties of Melia wild type and its cytotoxicity against T47D cell. The ethanolic extract of the Melia leaves was fractionated with n-hexane, ethyl acetate and water, and the secondary metabolites were obtained. The antioxidant properties were determined with IC50 DPPH (2,2-diphenyl-1-pycrylhydrazyl) radical and FRAP (ferric reducing antioxidant power), while the cytotoxicity was determined with the MTT method. The total phenolic (TPC) and β-sitosterol (SC) contents were also measured. The results showed that the ethyl acetate fraction had higher antioxidant and cytotoxic activities (IC50 211.89 ± 10.86 and 147.90 ± 8.49 μg/mL, respectively) than others. Significant (p < 0.05) correlations were observed between TPC, IC50DPPH, FRAP and IC50T47D. LC-EI MS analysis of the ethyl acetate fraction revealed the steroid and triterpenoid saponins, limonoids and quercetin glycosides, which influenced the medicinal properties of the Melia leaves. Melia azedarach L. wild type leaf extracts are a promising natural resource for managing breast cancer.Entities:
Keywords: Antioxidants; DPPH; FRAP; LCMS; Melia azedarach; T47D cytotoxic; TPC
Year: 2020 PMID: 32140442 PMCID: PMC7044715 DOI: 10.1016/j.btre.2020.e00437
Source DB: PubMed Journal: Biotechnol Rep (Amst) ISSN: 2215-017X
The quality parameters of M azedarach dried leaves, extract and fractions*.
| Parameter | Dried leaves |
|---|---|
| Identity | |
| Macroscopic appearance | Medium and deciduous tree, leaves is opposite non-decussate phyllotaxis with specific inipinnate (imparipinnate) compound leaves, 3–8 cm long, serrated edge, typical smelling when squeezed, dark green to pale green colour |
For the yields, values with different superscripts are significantly different (p < 0.05).
+ = present, - = absent.
E = ethanolic extract, FH = hexane fraction, FE = ethyl acetate fraction and FW = water fraction.
IC50T47D, IC50AA TPC and SC of the M azedarach extract and fractions*.
| Samples | (μg/mL) | (μg/mg) | |||
|---|---|---|---|---|---|
| IC50 T47D | IC50 AA | FRAP (RE/ sample) | TPC (GAE/ sample) | SC ( | |
| E | 628.05 ± 35.69c | 232.00 ± 11.00b | 106.20±1.53b | 102.18 ± 2.59c | 5.49 ± 0.37b |
| FH | 757.09 ± 21.57d | 574.25 ± 29.71c | 55.08±2.64a | 16.33 ± 0.23a | 17.38 ± 2.47c |
| FE | 147.90 ± 8.49b | 211.89 ± 10.86b | 157.75±2.51d | 109.43 ± 3.54d | 5.04 ± 0.12b |
| FW | 820.26 ± 8.25e | 229.32 ± 8.10b | 144.84±2.67c | 55.72 ± 1.36b | nda |
| R | -- | 11.78 ± 0.74a | -- | -- | -- |
| Doxo | 3.23 ± 0.22a | -- | -- | -- | |
IC50 = inhibition concentration, T47D = T47D cell line, AA = DPPH antioxidant activity, FRAP = ferric reducing antioxidant potency, RE = rutin equivalence, TPC = total phenolic content, GAE = gallic acid equivalence, SC = equivalent to β-sitosterol content, βSE = β-sitosterol equivalence, R = rutin, Doxo = doxorubicin, nd = not detectable, -- = not tested. TPC linear regression equation y = 0.0020x+0.0144, R2 = 0.9993; SC y = 624.32x+331.10, R2 = 0.9982; while rutin linearity y = 0.0009x+0.0048, R2=0.9803). Different superscript letters between the means in the same column, are statistically different significantly (p < 0.05).
Fig. 1Parameters histogram of the samples result. The lower IC50AA and IC50T47D of FE showed the potent of its antioxidant and cytotoxic than others samples.
Fig. 2LC- EI MS chromatogram results analysis and predictive phytochemicals content from the M. azedarach leaves ethyl acetate fraction. It contents of limonoid (toosendanin, meliacarpinin, 12-hydroxyamoorastatin and their derivates, meliarachin, salannin and salannal), flavonoid glycosides (quercetin-7-O-β-d-glucopyranoside and quercetin 3-O-(2′',6′'-digalloyl)-β-d-galactopyranoiside), saponins (triterpene and steroid glycosides), and triterpene aglycone.
Predictive compounds of FE M. azedarach.
| Peak No | Rt (minutes) | % area | m/z [M+H] | Predictive compounds [molecular formula, M] | References |
|---|---|---|---|---|---|
| 4 | 5.364 | 1.42 | 465 | Quercetin-7- | [ |
| 8 | 7.987 | 1.31 | 613 | Salannal [C34H44O10, 612.716] | [ |
| 9 | 8.841 | 3.27 | 763 | Quercetin 3- | [ |
| 13 | 10.041 | 1.72 | 573 | Meliarachin B [C30H36O11, 572.6] | [ |
| 14 | 10.474 | 3.71 | 683 | (2 | [ |
| 15 | 11.032 | 6.53 | 575 | Toosendanin [C30H38O11, 574.616] | [ |
| 16 | 11.474 | 6.75 | 697 | Methyl (23 | [ |
| 17 | 12.169 | 1.62 | 557,497 | toosendanin derivates [M–H2O+H]+ at 557.4 and [M–CH3COO+H]+ at 497.2 | [ |
| 18 | 12.802 | 2.50 | 537 | Cyclopenta[c]pyran-4-carboxylic acid, 1-( | [ |
| 19 | 13.265 | 1.14 | 597 | Salannin [C34H44O9, 596.7] | [ |
| 23 | 15.214 | 1.17 | 547 | Meliarachin H/I [C29H38O10, 546.6] | [ |
| 27 | 16.521 | 9.39 | 593, 533 | 12-hydroxyamoorastatin – acetyl derivate [C30H40O12, 592.23] | [ |
| 28 | 16.942 | 4.16 | 533 | 12-hydroxyamoorastatin [C28H36O10, 532.2308] | [ |
| 30 | 17.68 | 4.90 | 637 | 5-[17-(5,6-dihydroxy-6-methylheptan-2-yl)-3,12-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-2-yl]-oxy-3-hydroxy-3-methyl-5-oxopentanoic acid [C36H60O9, 636.4237] | [ |
| 32 | 18.438 | 40.80 | 621 | (2E)-6-(13,17-dihydroxy-7,7,12,16-tetramethyl-6-[(3,4,5-trihydroxyoxan-2-yl)-oxy]-pentacyclo-[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]-octadecan-15-yl)-2-methylhept-2-enoic acid [C35H56O9, 620.3924] | [ |